We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Top Buys

Rank Stock Value
1
PLAY icon
Dave & Buster's
PLAY
+$2.84M
2
LYV icon
Live Nation Entertainment
LYV
+$2.81M
3
WWW icon
Wolverine World Wide
WWW
+$2.72M
4
TSLA icon
Tesla
TSLA
+$2.63M
5
CALY
Callaway Golf Company
CALY
+$2.58M

Top Sells

Rank Stock Value
1
G icon
Genpact
G
+$3.61M
2
RLAY icon
Relay Therapeutics
RLAY
+$2.99M
3
EXTR icon
Extreme Networks
EXTR
+$2.33M
4
CASY icon
Casey's General Stores
CASY
+$2.21M
5
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
+$2.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MVIS icon
1251
Microvision
MVIS
$78.9M
$184K 0.02%
+3,400
New +$240K
AXDX
1252
DELISTED
Accelerate Diagnostics
AXDX
$183K 0.02%
+12,070
New +$200K
JOBY icon
1253
Joby Aviation
JOBY
$8.55B
$183K 0.02%
42,278
+23,114
+121% +$127K
ONB icon
1254
Old National Bancorp
ONB
$10.2B
$183K 0.02%
11,081
-44,455
-80% -$743K
AI icon
1255
C3.ai
AI
$1.59B
$182K 0.02%
+14,593
New +$262K
CRDF icon
1256
Cardiff Oncology
CRDF
$77.2M
$182K 0.02%
117,874
+579
+0.5% +$1.39K
TNYA icon
1257
Tenaya Therapeutics
TNYA
$163M
$182K 0.02%
+62,666
New +$292K
ABUS icon
1258
Arbutus Biopharma
ABUS
$915M
$181K 0.02%
94,800
+78,664
+488% +$185K
ET icon
1259
Energy Transfer Partners
ET
$69.3B
$181K 0.02%
+16,398
New +$183K
PK icon
1260
Park Hotels & Resorts
PK
$2.97B
$181K 0.02%
16,069
-70,133
-81% -$998K
WTTR icon
1261
Select Water Solutions
WTTR
$2.61B
$181K 0.02%
+25,953
New +$180K
WEBR
1262
DELISTED
Weber Inc.
WEBR
$181K 0.02%
+27,529
New +$201K
BHR
1263
Braemar Hotels & Resorts
BHR
$142M
$178K 0.02%
41,445
+30,557
+281% +$155K
CXM icon
1264
Sprinklr
CXM
$1.61B
$176K 0.02%
+19,115
New +$215K
CCCC icon
1265
C4 Therapeutics
CCCC
$412M
$175K 0.02%
19,905
-2,439
-11% -$25.3K
ROIC
1266
DELISTED
Retail Opportunity Investments Corp.
ROIC
$175K 0.02%
12,734
-3,401
-21% -$56.1K
AMTI
1267
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$175K 0.02%
179,714
+161,536
+889% +$285K
EYPT icon
1268
EyePoint Inc
EYPT
$1.2B
$173K 0.02%
+21,929
New +$204K
SKIN icon
1269
SkinHealth Systems
SKIN
$85.7M
$173K 0.02%
+14,659
New +$185K
LYLT
1270
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$173K 0.02%
143,049
+114,687
+404% +$298K
AAL icon
1271
American Airlines Group
AAL
$10.6B
$172K 0.02%
14,298
-11,170
-44% -$156K
ACTG icon
1272
Acacia Research
ACTG
$470M
$172K 0.02%
+42,470
New +$196K
HTZ icon
1273
Hertz
HTZ
$809M
$172K 0.02%
+10,556
New +$198K
QTTB icon
1274
Q32 Bio
QTTB
$464M
$172K 0.02%
5,940
-1,191
-17% -$48.6K
CTXR icon
1275
Citius Pharmaceuticals
CTXR
$18.7M
$171K 0.02%
+5,656
New +$155K
49 50
51
52 53

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.